Adult histiocyte disorders are a group of rare conditions characterised by an overproduction of white blood cells known as histiocytes. These cells are normally vital for destroying foreign substances and protecting the body from infection. However, in these disorders, their excessive numbers can lead to organ damage and tumour formation.
The most common form in adults is Langerhans Cell Histiocytosis (LCH). LCH occurs when specialised histiocytes, called dendritic cells, become too abundant in various tissues or organs. Only a few hundred adults in India are diagnosed with LCH each year, highlighting its rarity. While historically debated as either an inflammatory condition or a form of cancer, recent scientific discoveries, including the identification of genetic mutations, suggest that LCH is best defined as a form of blood-related cancer.
An extremely rare form of non-Langerhans cell histiocytosis with similar signs and symptoms to LCH. Due to its potential to affect critical organs such as the heart, brain, and kidneys, expert monitoring is crucial.
Another extremely rare form of non-Langerhans cell histiocytosis that often involves the lymph nodes, leading to painful lumps or abdominal pain from enlarged lymph nodes. It frequently develops alongside other blood-related cancers, such as lymphoma.
Although more commonly seen in children, RDD also occurs in adults. It typically causes enlarged lymph nodes in the neck which may resolve naturally without intervention. However, it can sometimes persist, requiring treatment, and may affect the bone, skin, nervous system, and other organs. RDD can also occur alongside other blood-related diseases, including Hodgkin lymphoma, or rheumatologic diseases such as lupus and rheumatoid arthritis.
The symptoms of LCH vary widely depending on the organ affected:
Pain in specific areas where bone is being eroded. Commonly affected sites include the skull, jaw, ribs, pelvis, and vertebrae, though any bone can be involved.
Development of single or multiple small red bumps, or an itchy and flaky appearance similar to eczema or psoriasis. Common sites include the scalp, ear canals, and vulva.
The appearance of painless, rubbery lumps in the neck, under the arms, or in the groin.
This is particularly noted in smokers, and the result may be a chronic cough or shortness of breath.
Often affecting the pituitary gland, which can cause a condition known as diabetes insipidus, leading to extreme thirst or excessive urination.
Important Note: It is important to note that none of these symptoms are a definitive sign of LCH. In some cases, such as when the disease begins in the liver or spleen, there may be no noticeable symptoms at all.
To reach a diagnosis, doctors typically perform a biopsy of the affected tissue, examining it under a microscope to identify abnormal-looking cells. This is followed by molecular tests to check for abnormal genes or proteins linked to the disease. Imaging tests and various laboratory tests are also essential in confirming the diagnosis and determining the extent of the disease's effects on the body.
Examination of affected tissue under microscope to identify abnormal cells
Testing for abnormal genes or proteins linked to the disease
Confirming diagnosis and determining extent of disease effects
The treatment approach for LCH is highly personalised, depending on the individual patient, the specific areas of the body affected, and the overall spread of the disease.
When LCH occurs in a single site, it can often be managed with surgery alone or through steroid injections into the affected area.
If the disease is present in several sites or involves a bodily system, such as the lymph system, chemotherapy is frequently required.
In cases where LCH arises in the lungs of cigarette smokers, simply stopping smoking can sometimes lead to a cure.
Some patients benefit from advanced medications that specifically target an abnormal protein found within the Langerhans cells. This approach highlights how scientific understanding of the disease's genetic and molecular mechanisms is translating directly into new, effective treatment options.
Treatment tailored to each patient's unique condition
Treatment based on specific areas of the body affected
Consideration of overall spread and severity of disease
Access to cutting-edge targeted therapies